FDA Approves Groundbreaking Brain Cancer Gene Therapy

FDA just approved a groundbreaking gene therapy for a rare, aggressive brain cancer — a personalized treatment that modifies a patient’s immune cells to hunt down tumors with a specific mutation found in 10% of cases. After years of setbacks and promising trial results, this approval offers new hope where options were scarce. Now, the real challenge begins: making it affordable and accessible while the FDA watches closely for long-term safety and effectiveness. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/1acca9e244d54363